AGT and atherosclerosis: Promotion of EndMT may be considered as a further possible mechanism of Angiotensin II (AngII)-mediated endothelial dysfunction, since the treatment with irbesartan attenuated it and slowed atherosclerosis in type II diabetes mellitus patients [47].